BRD4 and neoplasm: (1) The flow cytometry‐based drug screening experiments showed that bromodomain Containing 4 (BRD4) inhibitors can simultaneously reverse the expression of PD‐L1 in NSCLC tumour cells induced by radiotherapy and cisplatin treatment.